NanoEcho AB — Investor Relations & Filings

NanoEcho AB is a medical technology company developing a novel diagnostic method for early-stage rectal cancer. The company's technology is designed to accurately determine if cancer has spread to nearby lymph nodes, a critical factor for treatment planning. The patented method utilizes a combination of iron oxide-based nanoparticles as a contrast agent, a magnetic field, and advanced ultrasound to generate high-resolution images. By improving diagnostic precision, NanoEcho aims to enable more individualized treatment strategies, potentially reducing the number of unnecessary major surgical interventions. This approach seeks to enhance patient quality of life, optimize healthcare resources, and provide significant health economic benefits.